Search research articles
Contact Us
Filters
Showing results (331-340 of 609) with videos related to
Page
of 61
Sort By:
Journal of Drugs in Dermatology : JDD
|
December 31, 2004
Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis
Alice B Gottlieb, Kenneth B Gordon, Mark G Lebwohl, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 23, 2018
Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials
A Blauvelt, K Reich, M Lebwohl, et al.
Journal of Drugs in Dermatology : JDD
|
August 14, 2014
A randomized, prospective, sham-controlled study of localized narrow-band UVB phototherapy in the treatment of plaque psoriasis
Adriane A Levin, Saud Aleissa, Nicole Dumont, et al.
Dermatology and Therapy
|
July 14, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 Trials
Richard B Warren, Alice B Gottlieb, Joseph F Merola, et al.
Journal of Drugs in Dermatology : JDD
|
March 17, 2017
The International Dermatology Outcome Measures (IDEOM) Initiative: A Review and Update
Scott A Elman, Joseph F Merola, April W Armstrong, et al.
The New England Journal of Medicine
|
November 25, 2003
Etanercept as monotherapy in patients with psoriasis
Craig L Leonardi, Jerold L Powers, Robert T Matheson, et al.
The Journal of Dermatological Treatment
|
March 8, 2021
Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis
Steven R Feldman, Joseph F Merola, David M Pariser, et al.
Dermatology and Therapy
|
May 14, 2023
Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT Survey
Joseph F Merola, Alexis Ogdie, Alice B Gottlieb, et al.
The Journal of Rheumatology
|
August 5, 2025
Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual Meeting
Sarah Romanelli, Beth Childs, Vibeke Strand, et al.
Journal of Drugs in Dermatology : JDD
|
July 8, 2025
Pyoderma Gangrenosum in Pregnancy: A Systematic Review of Clinical Characteristics, Treatment Outcomes, and Maternofetal Implications
Gretchen D Ball, Sarah Romanelli, Jacob M Bodner, et al.
Page
of 61
Search research articles
Search
Showing results (331-340 of 609) with videos related to
Sort By:
Page
of 61
Journal of Drugs in Dermatology : JDD
|
December 31, 2004
Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis
Alice B Gottlieb, Kenneth B Gordon, Mark G Lebwohl, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 23, 2018
Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trials
A Blauvelt, K Reich, M Lebwohl, et al.
Journal of Drugs in Dermatology : JDD
|
August 14, 2014
A randomized, prospective, sham-controlled study of localized narrow-band UVB phototherapy in the treatment of plaque psoriasis
Adriane A Levin, Saud Aleissa, Nicole Dumont, et al.
Dermatology and Therapy
|
July 14, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 Trials
Richard B Warren, Alice B Gottlieb, Joseph F Merola, et al.
Journal of Drugs in Dermatology : JDD
|
March 17, 2017
The International Dermatology Outcome Measures (IDEOM) Initiative: A Review and Update
Scott A Elman, Joseph F Merola, April W Armstrong, et al.
The New England Journal of Medicine
|
November 25, 2003
Etanercept as monotherapy in patients with psoriasis
Craig L Leonardi, Jerold L Powers, Robert T Matheson, et al.
The Journal of Dermatological Treatment
|
March 8, 2021
Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis
Steven R Feldman, Joseph F Merola, David M Pariser, et al.
Dermatology and Therapy
|
May 14, 2023
Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT Survey
Joseph F Merola, Alexis Ogdie, Alice B Gottlieb, et al.
The Journal of Rheumatology
|
August 5, 2025
Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual Meeting
Sarah Romanelli, Beth Childs, Vibeke Strand, et al.
Journal of Drugs in Dermatology : JDD
|
July 8, 2025
Pyoderma Gangrenosum in Pregnancy: A Systematic Review of Clinical Characteristics, Treatment Outcomes, and Maternofetal Implications
Gretchen D Ball, Sarah Romanelli, Jacob M Bodner, et al.
Page
of 61